One year after Fetroja approval, Shionogi expands label to include difficult-to-treat pneumonia

A year after snagging approval in complicated urinary tract infections, Shionogi’s antibiotic Fetroja has added another indication to its label: hospital-acquired and ventilator-associated bacterial pneumonia.